I'm sure you all have seen the headlines on this one. If concerned and or interested in the topic, Dr. Lopez examines in objective detail what risks, if any, long chain fatty acids (the “fish oils” EPA/DHA would be in that category) present to the prostate.
Long-Chain Omega-3 Fatty Acids: Friend or Foe to Prostate?
More than meets the eye to recent controversy over omega-3 levels and prostate cancer risk—Lets take a closer look
Hector Lopez, MD, CSCS, FAAPMR
A large-scale prospective case-cohort study evaluating plasma fatty acid levels and prostate cancer risk, published in JNCI (Journal of the National Cancer Institute) online ahead of print on July 10th, 2013 has created quite the stir amongst media, health care professionals, nutrition researchers, and the dietary supplement industry…Again! To quote the great Yogi Berra, “It’s like déjà vu, all over again.”
This recent study was led by Drs. Alan Kristal from the Fred Hutchinson Cancer Research Center, and Theodore Brasky of The Ohio State University Comprehensive Cancer Center in the USA as a follow up to their 2011 study. This new study analyzed data and blood plasma phospholipid status from men who participated in the SELECT (Selenium and Vitamin E Cancer Prevention Trial) trial from 427 participating sites across Europe, USA, Canada and Puerto Rico. Blood was analyzed for 834 “cases” diagnosed with prostate cancer (156 of which were high-grade), and an age-matched subcohort, comparison group of 1,393 all of which were selected from the 35,533 participants.
Continued HERE
Bookmarks